163 related articles for article (PubMed ID: 12131658)
1. Prognostic importance of serum vascular endothelial growth factor in relation to platelet and leukocyte counts in human renal cell carcinoma.
Jacobsen J; Grankvist K; Rasmuson T; Ljungberg B
Eur J Cancer Prev; 2002 Jun; 11(3):245-52. PubMed ID: 12131658
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor as prognostic factor in renal cell carcinoma.
Jacobsen J; Rasmuson T; Grankvist K; Ljungberg B
J Urol; 2000 Jan; 163(1):343-7. PubMed ID: 10604387
[TBL] [Abstract][Full Text] [Related]
3. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor in the serum of patients with non-small cell lung cancer: correlation with platelet and leukocyte counts.
Choi JH; Kim HC; Lim HY; Nam DK; Kim HS; Yi JW; Chun M; Oh YT; Kang S; Park KJ; Hwang SC; Lee YH; Hahn MH
Lung Cancer; 2001; 33(2-3):171-9. PubMed ID: 11551412
[TBL] [Abstract][Full Text] [Related]
5. Elevated preoperative serum levels of angiogenic cytokines correlate to larger primary tumours and poorer survival in non-small cell lung cancer patients.
Brattström D; Bergqvist M; Hesselius P; Larsson A; Lamberg K; Wernlund J; Brodin O; Wagenius G
Lung Cancer; 2002 Jul; 37(1):57-63. PubMed ID: 12057868
[TBL] [Abstract][Full Text] [Related]
6. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
Poon RT; Lau CP; Cheung ST; Yu WC; Fan ST
Cancer Res; 2003 Jun; 63(12):3121-6. PubMed ID: 12810638
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic factors: vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) are not necessarily elevated in patients with advanced renal cell carcinoma.
Edgren M; Lennernäs B; Larsson A; Kälkner KM
Anticancer Res; 2001; 21(2B):1423-9. PubMed ID: 11396226
[TBL] [Abstract][Full Text] [Related]
8. Serum angiogenic activity: diagnostic relevance in renal cell carcinoma.
Beecken WD; Bentas W; Glienke W; Linneweber J; Jonas D; Binder J; Kramer W
Eur Urol; 2002 Oct; 42(4):364-9. PubMed ID: 12361902
[TBL] [Abstract][Full Text] [Related]
9. Increased serum levels of vascular endothelial growth factor in patients with renal cell carcinoma.
Sato K; Tsuchiya N; Sasaki R; Shimoda N; Satoh S; Ogawa O; Kato T
Jpn J Cancer Res; 1999 Aug; 90(8):874-9. PubMed ID: 10543260
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients.
Bachelot T; Ray-Coquard I; Menetrier-Caux C; Rastkha M; Duc A; Blay JY
Br J Cancer; 2003 Jun; 88(11):1721-6. PubMed ID: 12771987
[TBL] [Abstract][Full Text] [Related]
11. Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinoma.
Ljungberg B; Jacobsen J; Häggström-Rudolfssson S; Rasmuson T; Lindh G; Grankvist K
Urol Res; 2003 Oct; 31(5):335-40. PubMed ID: 14574539
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of serum vascular endothelial growth factor in patients with polycythaemia vera.
Theodoridou S; Vyzantiadis T; Vakalopoulou S; Perifanis V; Tziomalos K; Vyzantiadis A; Garipidou V
Acta Haematol; 2003; 110(1):16-9. PubMed ID: 12975551
[TBL] [Abstract][Full Text] [Related]
13. Renal cell carcinoma: relevance of angiogenetic factors.
Wechsel HW; Bichler KH; Feil G; Loeser W; Lahme S; Petri E
Anticancer Res; 1999; 19(2C):1537-40. PubMed ID: 10365140
[TBL] [Abstract][Full Text] [Related]
14. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
George ML; Eccles SA; Tutton MG; Abulafi AM; Swift RI
Clin Cancer Res; 2000 Aug; 6(8):3147-52. PubMed ID: 10955796
[TBL] [Abstract][Full Text] [Related]
15. VEGF concentrations in tumour arteries and veins from patients with rectal cancer.
Werther K; Bülow S; Hesselfeldt P; Jespersen NF; Svendsen MN; Nielsen HJ
APMIS; 2002 Sep; 110(9):646-50. PubMed ID: 12529018
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma.
Akbulut H; Altuntas F; Akbulut KG; Ozturk G; Cindoruk M; Unal E; Icli F
Cytokine; 2002 Nov; 20(4):184-90. PubMed ID: 12543084
[TBL] [Abstract][Full Text] [Related]
17. Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets.
Werther K; Christensen IJ; Nielsen HJ
Scand J Clin Lab Invest; 2002; 62(5):343-50. PubMed ID: 12387579
[TBL] [Abstract][Full Text] [Related]
18. Serum vascular endothelial growth factor load and interleukin-6 in cancer patients.
O'Byrne KJ; Dobbs N; Harris AL
Br J Cancer; 2000 Jun; 82(11):1895-6. PubMed ID: 10839310
[No Abstract] [Full Text] [Related]
19. Vascular endothelial growth factor levels in serum and plasma following esophageal cancer resection--relationship to platelet count.
Spence GM; Graham AN; Mulholland K; McAllister I; Sloan JM; Armstrong MA; Campbell FC; McGuigan JA
Int J Biol Markers; 2002; 17(2):119-24. PubMed ID: 12113578
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor platelet counts, and prognosis in renal cancer.
O'Byrne KJ; Dobbs N; Propper D; Smith K; Harris AL
Lancet; 1999 May; 353(9163):1494-5. PubMed ID: 10232320
[No Abstract] [Full Text] [Related]
[Next] [New Search]